share_log

赛生药业公布授出18万份购股权已获行使

Saisheng Pharmaceutical announced that 180,000 share options have been granted and have been exercised

新浪港股 ·  Apr 18 19:59

Saisheng Pharmaceutical (06600) announced that on April 18, 2024, according to the rules of the initial public offering after-sales share option plan: 7.167.36 million share options granted under the initial public offering after-sales share option plan have been vested; 706.84 million share options granted under the initial public offering after-sales share option plan have expired; and 180,000 share options granted under the initial public offering after-sales share option plan have been exercised.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment